Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
P-fimbriae, also known as pyelonephritis-associated pili (Pap), are hair-like surface appendages expressed by uropathogenic Escherichia coli (UPEC) that are critical for the colonization of the upper urinary tract (Roberts et al., 1994). These structures are essential virulence factors that facilitate the colonization of the upper urinary tract by binding specifically to Gal(alpha1-4)Gal-containing glycolipids on renal epithelial cells (Dodson et al., 2001). The binding is primarily mediated by the PapG adhesin, a protein located at the distal tip of the fimbria. Because P-fimbriae are crucial for the transition from bladder infection (cystitis) to kidney infection (pyelonephritis), they are significant targets for anti-adhesion therapies. Therapeutic approaches include the use of galabioside analogs to competitively inhibit binding and pilicides that disrupt the chaperone-usher pathway required for pilus assembly (Pinkner et al., 2006). Additionally, cranberry-derived proanthocyanidins have been shown to inhibit the adhesion of P-fimbriated E. coli to uroepithelial cells (Howell et al., 2005). Targeting these fimbriae offers a potential alternative to traditional antibiotics, which may help in reducing the emergence of antimicrobial resistance by disarming the pathogen's ability to colonize rather than killing the bacteria directly.
Competitive inhibition of PapG adhesin binding to host Gal(alpha1-4)Gal receptors and disruption of pilus biogenesis via the chaperone-usher pathway.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on P-fimbria (Pap pilus) (Pap).